These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1495750)

  • 1. Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.
    Finch RA; Chan PK
    Oncology; 1992; 49(3):223-6. PubMed ID: 1495750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
    Chan PK
    Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
    Yung BY; Bor AM; Chan PK
    Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
    Chan PK; Aldrich MB; Yung BY
    Cancer Res; 1987 Jul; 47(14):3798-801. PubMed ID: 2439199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cytotoxic drugs on translocation of nucleolar RNA helicase RH-II/Gu.
    Perlaky L; Valdez BC; Busch H
    Exp Cell Res; 1997 Sep; 235(2):413-20. PubMed ID: 9299166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
    Chan PK; Qi Y; Amley J; Koller CA
    Cancer Lett; 1996 Feb; 100(1-2):191-7. PubMed ID: 8620441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoprotein B23 translocation and modulation of actinomycin D and doxorubicin cytotoxicity by dipyridamole in HeLa cells.
    Bor AM; Chang FJ; Yung BY
    Int J Cancer; 1992 Oct; 52(4):658-63. PubMed ID: 1399149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis.
    Yung BY; Busch H; Chan PK
    Biochim Biophys Acta; 1985 Dec; 826(4):167-73. PubMed ID: 3907710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the reversibility of actinomycin D cytotoxicity in HeLa cells by verapamil.
    Yung BY; Chang FJ; Bor AM
    Cancer Lett; 1991 Dec; 60(3):221-7. PubMed ID: 1756512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation.
    Chan PK; Aldrich M; Busch H
    Exp Cell Res; 1985 Nov; 161(1):101-10. PubMed ID: 2414117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1).
    Yung BY; Busch RK; Busch H; Mauger AB; Chan PK
    Biochem Pharmacol; 1985 Nov; 34(22):4059-63. PubMed ID: 2415133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tumor cell sensitivity to mitomycin C by "B23 translocation" assay.
    Chan PK; Aldrich MB; Chakrabarty S
    Cancer Lett; 1988 Jun; 40(2):143-9. PubMed ID: 3133107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.
    Yung BY; Yang YH; Bor AM
    Int J Cancer; 1991 Jul; 48(5):779-84. PubMed ID: 2071236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-dependent effects of two consecutive, divided, low doses of actinomycin D on translocation of protein B23, inhibition of cell growth and RNA synthesis in HeLa cells.
    Yung BY; Chang FJ; Bor AM; Lee ES
    Int J Cancer; 1992 Sep; 52(2):317-22. PubMed ID: 1381705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of phosphoprotein B23 in proliferating and non-proliferating HeLa cells.
    Yung BY; Bor AM; Yang YH
    Int J Cancer; 1990 Aug; 46(2):272-5. PubMed ID: 2200756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D inhibition of monoclonal antibody binding to nucleolar phosphoprotein 37/5.2 (B23).
    Busch RK; Chan PK; Busch H
    Life Sci; 1984 Oct; 35(17):1777-85. PubMed ID: 6207410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants.
    Zatsepina OV; Todorov IT; Philipova RN; Krachmarov CP; Trendelenburg MF; Jordan EG
    Eur J Cell Biol; 1997 May; 73(1):58-70. PubMed ID: 9174672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
    Sweet P; Chan PK; Slater LM
    Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical localization of nucleophosmin and RH-II/Gu protein in nucleoli of HeLa cells after treatment with actinomycin D.
    Smetana K; Busch R; Chan PK; Smetana K; Busch H
    Acta Histochem; 2001 Jul; 103(3):325-33. PubMed ID: 11482378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The behavior of nucleolar proteins under the conditions of the reversible three-dimensional separation of the structural components of the nucleolus].
    Dudnik OA; Zatsepina OV
    Tsitologiia; 1995; 37(1-2):126-32. PubMed ID: 7571016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.